Kabra Drugs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 7.17 | 0.64 | TBA |
| Operating Expense | 7.66 | 0.24 | 0.53 |
| Net Profit | -0.50 | 0.39 | -0.54 |
| Net Profit Margin | -6.97 | 60.94 | TBA |
| Earning Per Share | -0.21 | 0.21 | -0.53 |
| EBIDTA | -0.50 | 0.40 | -0.54 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 7.17 |
| Operating Expense | 7.66 |
| Net Profit | -0.50 |
| Net Profit Margin | -6.97 |
| Earning Per Share | -0.21 |
| EBIDTA | -0.50 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 1.72 | 0.74 | 0.34 |
| Operating Profit Annual | -1.08 | -0.74 | -0.34 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | 0.01 | TBA | TBA |
| Net Profit Annual | -1.09 | -0.74 | -0.34 |
| Tax Annual | 0.00 | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 1.72 |
| Operating Profit Annual | -1.08 |
| Interest Annual | TBA |
| Depreciation | 0.01 |
| Net Profit Annual | -1.09 |
| Tax Annual | 0.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 2.67 | TBA | TBA |
| Cash Flow from Operations | -4.71 | -0.21 | -0.35 |
| Cash Flow from Investing | -0.05 | TBA | TBA |
| Cash Flow from Financing | 23.39 | 2.88 | 0.36 |
| Cash Flow at the End | 21.30 | 2.67 | TBA |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 2.67 |
| Cash Flow from Operations | -4.71 |
| Cash Flow from Investing | -0.05 |
| Cash Flow from Financing | 23.39 |
| Cash Flow at the End | 21.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | TBA |
| PBIT Margin (%) | TBA | TBA | TBA |
| PBT Margin (%) | TBA | TBA | TBA |
| Net PROFIT Margin (%) | TBA | TBA | TBA |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | 0.08 | 8.83 | TBA |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | 0.08 |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.04 | TBA | TBA |
| Total Current Assets Annual | 25.16 | 4.55 | 0.68 |
| Non Current Assets Annual | 0.07 | 0.02 | 0.02 |
| Total Shareholders Funds Annual | 24.65 | 1.08 | -0.73 |
| Total Assets Annual | 25.23 | 4.57 | 0.70 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.04 |
| Total Current Assets Annual | 25.16 |
| Non Current Assets Annual | 0.07 |
| Total Shareholders Funds Annual | 24.65 |
| Total Assets Annual | 25.23 |
No Data Availabe
